Translation of Anxiety Treatment to Youth with Autism Spectrum Disorders

Journal of Child and Family Studies

Volumn 22, Issue 3, 2013, Pages 405-413

  Selles, Robert R ^a   Storch, Eric A ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Anxiety; Autism spectrum disorders; Cognitive behavioral therapy; Psychopharmacology; Psychotherapy

Indexed keywords

EID: 84875403960     PISSN: 10621024     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10826-012-9593-1     Document Type: Review

References (91)

1. Abramowitz, J. S., Whiteside, S. P., & Deacon, B. J. (2005). The effectiveness of treatment for pediatric obsessive compulsive disorder: A meta-analysis. Behavior Therapy, 36, 55-63.
2. Abramowitz, J. S., Khandker, M., Nelson, C. A., Deacon, B. J., & Rygwall, R. (2006). The role of cognitive factors in the pathogenesis of obsessive-compulsive symptoms: A prospective study. Behaviour Research and Therapy, 44(9), 1361-1374.
3. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders-fourth edition-text revision. Washington, DC.
4. Arnold, L. E., Farmer, C., Kraemer, H. C., Davies, M., Witwer, A., Chuang, S., et al. (2010). Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. Journal of Child and Adolescent Psychopharmacology, 20(2), 83-93.
5. Attwood, T. (2003). Framework for behavioral interventions. Child and Adolescent Psychiatric Clinics of North America, 12, 65-86.
6. Autism Speaks. (2009, February 18). Autism speaks announces results reported for the study of floxetine in autism (SOFIA), first industry-sponsored trial for the autism clinical trials network (ACTN). In Autism speaks. Retrieved January 20, 2012.
7. Baron-Cohen, S. (1989). Do autistic children have obsessions and compulsions? British Journal of Clinical Psychology, 28(3), 193-200.
8. Baron-Cohen, S., Mortimore, C., Moriarty, J., Izaguirre, J., & Robertson, M. (1999). The prevalence of gilles de la tourette's syndrome in children and adolescents with autism. Journal of Child Psychology and Psychiatry, 40(2), 213-218.
9. Bellini, S. (2004). Social skill deficits and anxiety in high-functioning adolescents with autism spectrum disorders. Focus on Autism and Other Developmental Disabilities, 19, 78-86.
10. Ben-Sasson, A., Cermak, S. A., Orsmond, G. I., Tager-Flusberg, H., Kadlec, M. B., & Carter, A. S. (2008). Sensory clusters of toddlers with autism spectrum disorders: Differences in affective symptoms. Journal of Child Psychology and Psychiatry, 49(8), 817-825.
11. Boyd, K., Woodbury-Smith, M., & Szatmari, P. (2011). Managing anxiety and depressive symptoms in adults with autism-spectrum disorders. Journal of Psychiatry and Neuroscience, 36(4), E35-E36.
12. Buitelaar, J. K., van der Gaag, R. J., & van der Hoeven, J. (1998). Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: Results of an open-label study. Journal of Clinical Psychiatry, 59(2), 56-59.
13. Cardaciotto, L., & Herbert, J. D. (2004). Cognitive behavior therapy for social anxiety disorder in the context of Asperger's Syndrome: A single-subject report. Cognitive and Behavioral Practice, 11(1), 75-81.
14. CDC. (2012). Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 Sites, United States, 2008. MMWR Surveillance Summaries, 61(3), 1-24.
15. Chalfant, A. M., Rapee, R., & Carroll, L. (2007). Treating anxiety disorders in children with high functioning autism spectrum disorders: A controlled trial. Journal of Autism and Developmental Disorders, 37(10), 1842-1857.
16. Constantino, J. N., & Gruber, C. P. (2005). The social responsiveness scale (SRS) manual. Los Angeles: Western Psychological Services.
17. Cotugno, A. J. (2009). Social competence and social skills training and intervention for children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39(9), 1268-1277.
18. Couturier, J. L., & Nicolson, R. (2002). A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 12(3), 243-248.
19. Davis, T. E., Moree, B. N., Dempsey, T., Hess, J. A., Jenkins, W. S., Fodstad, J. C., et al. (2011). The effect of communication deficits on anxiety symptoms in infants and toddlers with autism spectrum disorders. Behavior Therapy, 43(1), 142-152.
20. de Bruin, E. I., Ferdinand, R. F., Meester, S., de Nijs, P. F., & Verheij, F. (2007). High rates of psychiatric co-morbidity in PDD-NOS. Journal of Autism and Developmental Disorders, 37(5), 877-886.
21. Deacon, B. J., & Abramowitz, J. S. (2004). Cognitive and behavioral treatments for anxiety disorders: A review of meta-analytic findings. Journal of Clinical Psychology, 60(4), 429-441.
22. DeLong, G. R., Ritch, C. R., & Burch, S. (2002). Fluoxetine response in children with autistic spectrum disorders: Correlation with familial major affective disorder and intellectual achievement. Developmental Medicine and Child Neurology, 44(10), 652-659.
23. DeLong, G. R., Teague, L. A., & McSwain Kamran, M. (1998). Effects of fluoxetine treatment in young children with idiopathic autism. Developmental Medicine and Child Neurology, 40(8), 551-562.
24. Drahota, A., Wood, J. J., Sze, K. M., & van Dyke, M. (2011). Effects of cognitive behavioral therapy on daily living skills in children with high-functioning autism and concurrent anxiety disorders. Journal of Autism and Developmental Disorders, 41(3), 257-265.
25. Durham, R. C., Chambers, J. A., MacDonald, R. R., Power, K. G., & Major, K. (2003). Does cognitive-behavioural therapy influence the long-term outcome of generalized anxiety disorder? An 8-14 year follow-up of two clinical trials. Psychological Medicine, 33(3), 499-509.
26. Ehrenreich, J. T., Simpson, G., & Wood, J. J. (2009). Anxiety-focused interventions for youth with autism: Manual for adolescents transitioning to adulthood. University of Miami. Unpublished treatment manual.
27. Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatric Research, 65(6), 591-598.
28. Gadow, K. D., Devincent, C. J., Pomeroy, J., & Azizian, A. (2005). Comparison of DSM-IV symptoms in elementary school-age children with PDD versus clinic and community samples. Autism, 9(4), 392-415.
29. Gadow, K. D., Devincent, C., & Schneider, J. (2008). Predictors of psychiatric symptoms in children with an autism spectrum disorder. Journal of Autism and Developmental Disorders, 38(9), 1710-1720.
30. Garcia-Lopez, L. J., Olivares, J., Beidel, D., Albano, A. M., Turner, S., & Rosa, A. I. (2006). Efficacy of three treatment protocols for adolescents with social anxiety disorder: A 5-year follow-up assessment. Journal of Anxiety Disorders, 20(2), 175-191.
31. Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin, A., Spencer, T., et al. (2003). Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. American Journal of Psychiatry, 160(11), 1919-1928.
32. Ghaziuddin, M., Ghaziuddin, N., & Greden, J. (2002). Depression in persons with autism: Implications for research and clinical care. Journal of Autism and Developmental Disorders, 32(4), 299-306.
33. Gillott, A., Furniss, F., & Walter, A. (2001). Anxiety in high-functioning children with autism. Autism, 5(3), 277-286.
34. Green, S. A., Ben-Sasson, A., Soto, T. W., & Carter, A. S. (2011). Anxiety and sensory over-responsivity in toddlers with autism spectrum disorders: Bidirectional effects across time. Journal of Autism and Developmental Disorders.
35. Henry, C. A., Steingard, R., Venter, J., Guptill, J., Halpern, E. F., & Bauman, M. (2006). Treatment outcome and outcome associations in children with pervasive developmental disorders treated with selective serotonin reuptake inhibitors: A chart review. Journal of Child and Adolescent Psychopharmacology, 16(1/2), 187-195.
36. Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., et al. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30(3), 582-589.
37. Hwang, B., & Hughes, C. (2000). The effects of social interactive training on early social communicative skills of children with autism. Journal of Autism and Developmental Disorders, 30, 331-343.
38. Kanner, L. (1943). Autistic disturbances of affective contact. The Nervous Child, 2, 217-250.
39. Kelly, A. B., Garnett, M. S., Attwood, T., & Peterson, C. (2008). Autism spectrum symptomatology in children: The impact of family and peer relationships. Journal of Abnormal Child Psychology, 36(7), 1069-1081.
40. Kendall, P. C., & Choudhury, M. S. (2003). Children and adolescents in cognitive-behavioral therapy: Some past efforts and current advances, and the challenges in our future. Cognitive Therapy and Research, 27(1), 89-104.
41. Kendall, P. C., Hudson, J. L., Gosch, E., Flannery-Schroeder, E., & Suveg, C. (2008). Cognitive-behavioral therapy for anxiety disordered youth: a randomized clinical trial evaluating child and family modalities. Journal of Consulting and Clinical Psychology, 76(2), 282-297.
42. Kendall, P. C., Safford, S., Flannery-Schroeder, E., & Webb, A. (2004). Child anxiety treatment: Outcomes in adolescence and impact on substance use and depression at 7. 4-year follow-up. Journal of Consulting and Clinical Psychology, 72(2), 276-287.
43. Kim, J. A., Szatmari, P., Bryson, S. E., Streiner, D. L., & Wilson, F. J. (2000). The prevalence of anxiety and mood problems among children with autism and Asperger syndrome. Autism, 4(2), 117.
44. King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry, 66(6), 583-590.
45. Klin, A., Danovitch, J. H., Merz, A. B., & Volkmar, F. R. (2007). Circumscribed interests in higher functioning individuals with autism spectrum disorders: An exploratory study. Research and Practice for Persons with Severe Disabilities, 32(2), 89-100.
46. Lang, R., Regester, A., Lauderdale, S., Ashbaugh, K., & Haring, A. (2010). Treatment of anxiety in autism spectrum disorders using cognitive behaviour therapy: A systematic review. Developmental Neurorehabilitation, 13(1), 53-63.
47. Leskovec, T. J., Rowles, B. M., & Findling, R. L. (2008). Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harvard Review of Psychiatry, 16(2), 97-112.
48. Levant, R. F. (2005). Report of the 2005 presidential task force on evidence-based practice. In American psychological association. Retrieved March 31, 2012, from http://www. apa. org/practice/resources/evidence/evidence-based-report. pdf.
49. Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., et al. (2006). Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. Journal of Autism and Developmental Disorders, 36(7), 849-861.
50. Lord, C., Wagner, A., Rogers, S., Szatmari, P., Aman, M., Charman, T., et al. (2005). Challenges in evaluating psychosocial interventions for autistic spectrum disorders. Journal of Autism and Developmental Disorders, 35(6), 695-708. Discussion 709-611.
51. Manassis, K., Avery, D., Butalia, S., & Mendlowitz, S. (2004). Cognitive-behavioral therapy with childhood anxiety disorders: Functioning in adolescence. Depression and Anxiety, 19(4), 209-216.
52. Mancuso, E., Faro, A., Joshi, G., & Geller, D. A. (2010). Treatment of pediatric obsessive-compulsive disorder: A review. Journal of Child and Adolescent Psychopharmacology, 20(4), 299-308.
53. Martin, A., Koenig, K., Anderson, G. M., & Scahill, L. (2003). Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study. Journal of Autism and Developmental Disorders, 33(1), 77-85.
54. Matson, J. L., & Shoemaker, M. (2009). Intellectual disability and its relationship to autism spectrum disorders. Research in Developmental Disabilities, 30(6), 1107-1114.
55. McCormick, L. H. (1997). Treatment with buspirone in a patient with autism. Archives of Family Medicine, 6(4), 368-370.
56. McDougle, C. J., Brodkin, E. S., Naylor, S. T., Carlson, D. C., Cohen, D. J., & Price, L. H. (1998). Sertraline in adults with pervasive developmental disorders: A prospective open-label investigation. Journal of Clinical Psychopharmacology, 18(1), 62-66.
57. McDougle, C. J., Kresch, L. E., & Posey, D. J. (2000). Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors. Journal of Autism and Developmental Disorders, 30(5), 427-435.
58. McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53(11), 1001-1008.
59. Mercier, C., Mottron, L., & Belleville, S. (2000). A psychosocial study on restricted interests in high functioning persons with pervasive developmental disorders. Autism, 4(4), 406-425.
60. Mills, R., & Wing, L. (2005). Researching interventions in ASD and priorities for research: Surveying the membership of the NAS. London: National Autistic Society.
61. Muris, P., Steerneman, P., Merckelbach, H., Holdrinet, I., & Meesters, C. (1998). Comorbid anxiety symptoms in children with pervasive developmental disorders. Journal of Anxiety Disorders, 12(4), 387-393.
62. Murphy, T. K., Segarra, A., Storch, E. A., & Goodman, W. K. (2008). SSRI adverse events: How to monitor and manage. International Review of Psychiatry, 20(2), 203-208.
63. Namerow, L. B., Thomas, P., Bostic, J. Q., Prince, J., & Monuteaux, M. C. (2003). Use of citalopram in pervasive developmental disorders. Journal of Developmental and Behavioral Pediatrics, 24(2), 104-108.
64. Ooi, Y. P., Lam, C. M., Sung, M., Tan, W. T., Goh, T. J., Fung, D. S., et al. (2008). Effects of cognitive-behavioural therapy on anxiety for children with high-functioning autistic spectrum disorders. Singapore Medical Journal, 49(3), 215-220.
65. Oswald, D. P., & Sonenklar, N. A. (2007). Medication use among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17(3), 348-355.
66. Posey, D. I., Litwiller, M., Koburn, A., & McDougle, C. J. (1999). Paroxetine in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 38(2), 111-112.
67. Rao, P. A., Beidel, B. C., & Murray, M. J. (2008). Social skills interventions for children with Asperger's syndrome or high-functioning autism: A review and recommendations. Journal of Autism and Developmental Disorders, 38, 353-361.
68. Realmuto, G. M., August, G. J., & Garfinkel, B. D. (1989). Clinical effect of buspirone in autistic children. Journal of Clinical Psychopharmacology, 9(2), 122-125.
69. Reaven, J., Blakeley-Smith, A., Culhane-Shelburne, K., & Hepburn, S. (2012). Group cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: A randomized trial. Journal of Child Psychology and Psychiatry, 53(4), 410-419.
70. Rufer, M., Hand, I., Alsleben, H., Braatz, A., Ortmann, J., Katenkamp, B., et al. (2005). Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: A 7-year follow-up of a randomized double-blind trial. European Archives of Psychiatry and Clinincal Neuroscience, 255(2), 121-128.
71. RUPP (Research Unit on Pediatric Psychopharmacology) Anxiety Study Group. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344(17), 1279-1285.
72. Russell, A. J., Mataix-Cols, D., Anson, M., & Murphy, D. G. (2005). Obsessions and compulsions in Asperger syndrome and high-functioning autism. British Journal of Psychiatry, 186, 525-528.
73. Russell, E., & Sofronoff, K. (2005). Anxiety and social worries in children with Asperger syndrome. Australian and New Zealand Journal of Psychiatry, 39(7), 633-638.
74. Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry, 47(8), 921-929.
75. Snead, R. W., Boon, F., & Presberg, J. (1994). Paroxetine for self-injurious behavior. Journal of the American Academy of Child and Adolescent Psychiatry, 33(6), 909-910.
76. Sofronoff, K., Attwood, T., & Hinton, S. (2005). A randomised controlled trial of a CBT intervention for anxiety in children with Asperger syndrome. Journal of Child Psychology and Psychiatry, 46(11), 1152-1160.
77. Spiker, M. A., Lin, C. E., van Dyke, M., & Wood, J. J. (2011). Restricted interests and anxiety in children with autism. Autism,. doi: 10. 1177/1362361311401763.
78. Steingard, R. J., Zimnitzky, B., DeMaso, D. R., Bauman, M. L., & Bucci, J. P. (1997). Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. Journal of Child and Adolescent Psychopharmacology, 7(1), 9-15.
79. Stewart, R. E., & Chambless, D. L. (2009). Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: A meta-analysis of effectiveness studies. Journal of Consulting and Clinical Psychology, 77(4), 595-606.
80. Storch, E. A., Ehrenreich-May, J., Wood, J. J., Jones, A. M., De Nadai, A. S., Lewin., & A. B., Murphy, T. K. (in press). Multiple informant agreement on the anxiety disorders interview schedule in youth with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology.
81. Storch, E. A., Geffken, G. R., Merlo, L. J., Jacob, M. L., Murphy, T. K., Goodman, W. K., et al. (2007). Family accommodation in pediatric obsessive-compulsive disorder. Journal of Clinical Child and Adolesc Psychology, 36(2), 207-216.
82. Storch, E. A., Mariaskin, A., & Murphy, T. K. (2009). Psychotherapy for obsessive-compulsive disorder. Current Psychiatry Reports, 11(4), 296-301.
83. Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753-2766.
84. Warren, Z., Veenstra-VanderWeele, J., Stone, W., Bruzek, J. L., Nahmias, A. S., Foss-Feig, J. H., & McPheeters, M. L. (2011). Therapies for children with autism spectrum disorders. Comparative effectiveness review, 12 edn, vol. 26. Rockville, MD: Agency for Healthcare Research and Quality.
85. Weisbrot, D. M., Gadow, K. D., DeVincent, C. J., & Pomeroy, J. (2005). The presentation of anxiety in children with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 15(3), 477-496.
86. West, L., Brunssen, S. H., & Waldrop, J. (2009). Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors. Journal for Specialists in Pediatric Nursing, 14(3), 183-191.
87. White, S. W., Albano, A. M., Johnson, C. R., Kasari, C., Ollendick, T., Klin, A., et al. (2010). Development of a cognitive-behavioral intervention program to treat anxiety and social deficits in teens with high-functioning autism. Clinical Child and Family Psychology Review, 13(1), 77-90.
88. Wood, J. J., Drahota, A., Sze, K., Har, K., Chiu, A., & Langer, D. A. (2009a). Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: A randomized, controlled trial. Journal of Child Psychology and Psychiatry, 50(3), 224-234.
89. Wood, J. J., Drahota, A., Sze, K., van Dyke, M., Decker, K., Fujii, C., et al. (2009b). Brief report: Effects of cognitive behavioral therapy on parent-reported autism symptoms in school-age children with high-functioning autism. Journal of Autism and Developmental Disorders, 39(11), 1608-1612.
90. Wood, J. J., Fujii, C., & Renno, P. (2011). Cognitive behavioral therapy in high-functioning autism: Review and recommendations for treatment development. In B. Reichow, P. Doehring, D. V. Cicchetti, & F. R. Volkmar (Eds.), Evidence-based practices and treatments for children with autism (pp. 197-230). New York, NY: Springer.
91. Zandt, F., Prior, M., & Kyrios, M. (2007). Repetitive behaviour in children with high functioning autism and obsessive compulsive disorder. Journal of Autism and Developmental Disorders, 37(2), 251-259.